Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Radiotherapy. Found 52 abstracts

no pagination
Esposito AC, Crawford J, Sigurdson ER, Handorf EA, Hayes SB, Boraas M, Bleicher RJ. Omission of radiotherapy after breast conservation surgery in the postneoadjuvant setting. Journal of Surgical Research. 2018 Jan;221:49-57.   PMCID: PMC5729922
Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol. 2017 May;71(5):766-73.
Xu MJ, Chu C, Rubin S, Lin LL. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma. Am J Clin Oncol. 2017 Dec;40(6):598-604.   PMCID: PMC4733581
Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: A systematic review. Cancer Treat Rev. 2017 Feb;53:47-52.
Schiech L. Tonsillar cancer: What nurses need to know. Nursing. 2016 Jul;46(7):36-44.
Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: A systematic review. Cancer Treat Rev. 2016 Dec 22;53:47-52.
Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: A systematic review. Cancer Treat Rev. 2016 Dec 22;53:47-52.
Dai X, Zhao Y, Liang Z, Dassarath M, Wang L, Jin L, Chen L, Dong J, Price RA, Ma CM. Volumetric-modulated arc therapy for oropharyngeal carcinoma: a dosimetric and delivery efficiency comparison with static-field IMRT. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB). 2015 Feb;31(1):54-9.   PMCID: PMC4282814
Galloway TJ, Wirth LJ, Colevas AD, Gilbert J, Bauman JE, Saba NF, Raben D, Mehra R, Ma AW, Atoyan R, Wang J, Burtness B, Jimeno A. A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2015 Apr;21(7):1566-73.
Hamstra DA, Bae K, Hanks G, Hu C, Shipley WU, Pan CC, Roach M, Lawton CA, Sandler HM. Impact of Biochemical Failure Classification on Clinical Outcome: A Secondary Analysis of Radiation Therapy Oncology Group 9202 and 9413. Cancer. 2015 Mar;121(6):844-52.   PMCID: 4657945
Bagshaw H, Ruth K, Horwitz EM, Chen DY, Buyyounouski MK. Does family history of prostate cancer affect outcomes following radiotherapy?. Radiotherapy and Oncology. 2014 Feb;110(2):229-34.   PMCID: 3991234
Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Medical Dosimetry. 2014 Jan;39(2):185-9.   PMCID: No NIH funding
Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Med Dosim. 2014 Jan;39(2):185-9.
Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Lustig R, Konski AA, Benson AB, Macdonald JS, Rich TA, Willett CG. FAILURE TO ADHERE TO PROTOCOL SPECIFIED RADIATION THERAPY GUIDELINES WAS ASSOCIATED WITH DECREASED SURVIVAL IN RTOG 9704-A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS. International Journal of Radiation Oncology Biology Physics. 2012 Feb;82(2):809-16.   PMCID: PMC133855
Davis BJ, Horwitz EM, Lee WR, Crook JM, Stock RG, Merrick GS, Butler WM, Grimm PD, Stone NN, Potters L, Zietman AL, Zelefsky MJ. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy. 2012 Jan;11(1):6-19.   PMCID: not NIH funded
Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. RADIATION THERAPY ONCOLOGY GROUP 0247: A RANDOMIZED PHASE II STUDY OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Mar;82(4):1367-75.   PMCID: PMC3208721
Klayton TL, Ruth K, Horwitz EM, Uzzo RG, Kutikov A, Chen DY, Sobczak M, Buyyounouski MK. Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer. Radiotherapy and Oncology. 2011 Dec;101(3):508-12.   PMCID: PMC3225561
Ma CM, Luxton G, Orton CG. Point/counterpoint: pulsed reduced dose rate radiation therapy is likely to become the treatment modality of choice for recurrent cancers. Med Phys. 2011 Sep;38(9):4909-11.   PMCID: not NIH funded
Buyyounouski MK. Androgen deprivation therapy in high-risk prostate cancer. Oncology (Williston Park). 2010 Aug;24(9):806, 809.   PMCID: Not NIH funded
Chen LL, Paskalev K, Xu X, Zhu J, Wang L, Price RA, Hu W, Feigenberg SJ, Horwitz EM, Pollack A, Ma CM. Rectal dose variation during the course of image-guided radiation therapy of prostate cancer. Radiotherapy and Oncology. 2010 May;95(2):198-202.   PMCID: not NIH funded
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Radiotherapy

Radiotherapy radiotherapy Aged therapy adverse effects Middle Aged Cancer methods Myelofibrosis Male Toxicity Radiation oncology Meta-analysis therapeutic use Leukemia Palliation Chemoradiotherapy Lymphoma pathology Female Splenomegaly Dosimetry Adult Local Neoplasm Recurrence Dose Fractionation Breast cancer mortality Prostate cancer Imrt radiation effects Radiation Dosage Prostatic Neoplasms Quality assurance surgery Intensity-Modulated Radiotherapy Nuclear Medicine & Medical Imaging Radiology trial Treatment Outcome 80 and over Aged Squamous Cell Carcinoma Prostate Oncology administration & dosage Brachytherapy Combined Modality Therapy Neoplasm Metastasis i seed implantation complications re-optimization Standard biochemical failure Papillomaviridae Neoplasms breast-cancer chemoradiotherapy Head and Neck Neoplasms FAILURE risk Carcinosarcoma Cohort Studies Breast postimplant united-states Antineoplastic Agents acute urinary Radical prostatectomy hospital volume ii escalation prostate-specific antigen failure rectal-cancer phase-iii trial experience Spleen Clear Cell Adenocarcinoma Organs at Risk dosimetric analysis Palatine Tonsil Kallikreins postoperative radiotherapy Maximum Tolerated Dose nursing Volumetric-modulated arc therapy Rectal epidemiology Endometrioid Carcinoma Oropharyngeal Neoplasms critical-appraisal Conformal preoperative radiotherapy external-beam radiation Family history blood Chemotherapy ADJUVANT CHEMOTHERAPY Cisplatin Guideline Neoadjuvant therapy pubic arch interference Breast Neoplasms Hydroxamic Acids IRRADIATION Rectal dose Oropharyngeal carcinoma Carcinoma quality-of-life Clinical Trials as Topic Salvage Therapy Proportional Hazards Models Hematologic Neoplasms Safety body-mass index Young Adult Gleason 9 chemotherapy Radiometry Nursing Diagnosis Paclitaxel 1980 aryulu kkn-international journal of radiation oncology biology physics-v6-p1261 target localization androgen deprivation therapy drug effects Interstitial Radiotherapy Dosage ErbB-2 Receptor Epidermal Growth Factor Receptor men younger POSTMASTECTOMY errors Radiation therapy RADIATION-THERAPY Hysterectomy retention Retrospective Studies competing Quinazolines group protocol 92-02 Prognosis Course of treatment Tonsillectomy Pancreatic adenocarcinoma external-beam radiotherapy Androgen Antagonists chemoradiation Segmental mastectomy androgen deprivation Antineoplastic Combined Chemotherapy Protocols Abdominal Neoplasms RADIOTHERAPY
Last updated on Friday, January 05, 2018